OMDA logo
OMDA NASDAQ US

Omada Health, Inc. - Common Stock

Health Care · Health Care Website · IPO Jun 2025
$12.58
▼ $-0.03 (-0.24%)
Vol 1.0M
4
Quality Score
fail
Mkt Cap
$913.8M
Margin
-18.4%
D/E
0.00
Beta
3.03
52W
$14–$28

Wall Street Consensus

17 analysts · Apr 2026
2
Strong Buy
12
Buy
3
Hold
0
Sell
0
Strong Sell
82.4%
Buy Rating

Price Chart

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.05 $0.08 +$0.13
Sep 2025 $-0.08 $-0.06 +$0.02
Jun 2025 $-0.26 $-0.24 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM)
P/E (TTM)
Net Margin -8.6% -21.6% -21.6% -21.6% -18.4% -18.4%
Gross Margin 65.7% 61.2% 61.2% 61.2% 62.2% 62.2%
D/E Ratio 13.99 13.99 13.99 13.99 0.00 0.00
Current Ratio 4.68 4.68 4.68 4.68 3.63 3.63

Key Ratios

P/S (TTM)
2.58
EPS (TTM)
$-1.17
52W High
$28.40
52W Low
$14.14
$14.14 52-Week Range $28.40

How does OMDA compare to Health Care peers?

Peer group: Micro-cap Health Care (All) · 241 companies

OMDA valuation vs Health Care peers

P/E ratio
0% below peers (30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
2.6
0% above peers (2.6)
vs Peers
vs Industry
Fair value
P/B ratio
0% below peers (2.8)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.7%)
vs Peers
vs Industry
Low yield

OMDA profitability vs Health Care peers

ROE
0% below peers (-38.5%)
vs Peers
vs Industry
Top tier
Net margin
-18.4%
26% above peers (-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
62.2%
17% above peers (52.9%)
vs Peers
vs Industry
Below avg
ROA
0% below peers (-21.2%)
vs Peers
vs Industry
Top tier

OMDA financial health vs Health Care peers

D/E ratio
0.0
100% below peers (19.3)
vs Peers
vs Industry
Low debt
Current ratio
3.6
68% above peers (2.2)
vs Peers
vs Industry
Below avg
Beta
3.0
188% above peers (1.1)
vs Peers
vs Industry
More volatile

OMDA fundamentals radar

OMDA Peer median Industry

OMDA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

OMDA vs peers: key metrics

Latest News

No related news yet